A1LN34 Stock Chart & Stats
R$69.20
R$1.78(2.64%)
―
--
Day’s Range― - ―
52-Week RangeR$10.00 - R$135.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)327.00
Market Cap
R$184.45B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)61631.6
Beta-0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,670,251,500
10 Day Avg. Volume53
30 Day Avg. Volume327
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
A1LN34 FAQ
What was Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s price range in the past 12 months?
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh lowest stock price was R$10.00 and its highest was R$135.00 in the past 12 months.
What is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s market cap?
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s market cap is R$184.45B.
When is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s earnings last quarter?
Currently, no data Available
Is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh overvalued?
According to Wall Street analysts Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s price is currently Undervalued.
Does Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh pay dividends?
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh does not currently pay dividends.
What is Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s EPS estimate?
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh have?
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh has 2,670,251,500 shares outstanding.
What happened to Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh?
Currently, no hedge funds are holding shares in BR:A1LN34
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BeiGene Ltd ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR
―
Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs
―
Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
―
IQVIA Holdings Inc Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
―
Teva Pharmaceutical Industries Ltd Unsponsored Brazilian Depositary Receipt Repr 0.5 ADR
―